# Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

> **NCT01684787** · PHASE4 · COMPLETED · sponsor: **Miguel Santin** · enrollment: 80 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peginterferon alfa-2a + ribavirin in normal ALT
- **DRUG:** Peginterferon alfa-2a + ribavirin in elevated ALT

## Key facts

- **NCT ID:** NCT01684787
- **Lead sponsor:** Miguel Santin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01684787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01684787, "Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01684787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*